UF146

N/A

Report date: 2022/10/31 16:48:45

Base Information

Drug NameUF146
Drug Alias NameUF-146
ClassificationOther
Mechanisms of ActionE3 ubiquitin-protein ligase UHRF1 inhibitors
TargetsE3 ubiquitin-protein ligase UHRF1
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A